olaparib,bevacizumab
roche,astrazeneca,merck
['vance', 'solo-1', 'ovarian', 'paola-1', '$azn', '$mrk']
in patients with first-line advanced ovarian cancers. new findings from the solo-1 and paola-1 studies were presented at the european society for medical oncology ( ) conference, which kicked off on friday. $azn $mrk #ovariancancer